🔴 Gyre Therapeutics is trading 5.3% down today as oil and Treasury yields pressured equity valuations

Gyre Therapeutics is trading 5.3% lower at $7.09, apparently amid broader risk-off sentiment as rising oil prices and Treasury yields pressured equity valuations.

• No new company-specific announcement or regulatory event surfaced for September 23, 2026.
• The Nasdaq Composite fell 1.05% and the S&P 500 fell 0.56%; biotech rose 2.07%, making sector weakness unlikely.
• Confidence is medium: the macro backdrop aligns, but no direct company-specific cause was reported.